Acrospire Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-200
| Closed | -$16K | – | 1521 |
|
|
2017
Q2 | $16K | Sell |
200
-200
| -50% | -$16K | 0.02% | 1647 |
|
|
2017
Q1 | $33K | Sell |
400
-1,100
| -73% | -$90.8K | 0.03% | 1303 |
|
|
2016
Q4 | $119K | Buy |
+1,500
| New | +$119K | 0.05% | 792 |
|
|
2016
Q3 | – | Sell |
-700
| Closed | -$27K | – | 2199 |
|
|
2016
Q2 | $27K | Sell |
700
-300
| -30% | -$11.6K | 0.02% | 1429 |
|
|
2016
Q1 | $41K | Buy |
+1,000
| New | +$41K | 0.03% | 1117 |
|